EC
Euclidean Capital’s Foghorn Therapeutics FHTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.4M | Hold |
1,573,761
| – | – | 2.42% | 4 |
|
|
2025
Q1 | $5.74M | Hold |
1,573,761
| – | – | 2.16% | 3 |
|
|
2024
Q4 | $7.43M | Hold |
1,573,761
| – | – | 1.01% | 5 |
|
|
2024
Q3 | $14.7M | Hold |
1,573,761
| – | – | 1.62% | 4 |
|
|
2024
Q2 | $9.05M | Hold |
1,573,761
| – | – | 1.14% | 3 |
|
|
2024
Q1 | $10.6M | Hold |
1,573,761
| – | – | 1.35% | 5 |
|
|
2023
Q4 | $10.2M | Hold |
1,573,761
| – | – | 1.14% | 6 |
|
|
2023
Q3 | $7.87M | Hold |
1,573,761
| – | – | 1.72% | 8 |
|
|
2023
Q2 | $11.1M | Buy |
1,573,761
+312,500
| +25% | +$2.2M | 2.85% | 6 |
|
|
2023
Q1 | $7.82M | Hold |
1,261,261
| – | – | 6.86% | 5 |
|
|
2022
Q4 | $8.05M | Hold |
1,261,261
| – | – | 7.53% | 6 |
|
|
2022
Q3 | $10.8M | Hold |
1,261,261
| – | – | 10.05% | 3 |
|
|
2022
Q2 | $17.2M | Hold |
1,261,261
| – | – | 14.59% | 3 |
|
|
2022
Q1 | $19.2M | Hold |
1,261,261
| – | – | 11.16% | 3 |
|
|
2021
Q4 | $28.8M | Hold |
1,261,261
| – | – | 16.4% | 2 |
|
|
2021
Q3 | $17.6M | Hold |
1,261,261
| – | – | 8.54% | 5 |
|
|
2021
Q2 | $13.5M | Hold |
1,261,261
| – | – | 4.37% | 8 |
|
|
2021
Q1 | $16.6M | Hold |
1,261,261
| – | – | 5.56% | 6 |
|
|
2020
Q4 | $25.6M | Buy |
+1,261,261
| New | +$25.6M | 5.41% | 5 |
|